FindTrial
Sign In

Evaluation of Prostate Cancer Margins

Evaluation of Prostate Cancer Margins

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05317143
Enrollment
100
Registered
2022-04-07
Start date
2022-02-22
Completion date
2022-11-10
Last updated
2025-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate Cancer

Brief summary

Pathological assessment of prostate tissue

Interventions

OTHEREvaluation of prostate cancer margins

Evaluation of prostate cancer margins

Sponsors

Intuitive Surgical
Lead SponsorINDUSTRY

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Diagnosed with prostate cancer * Subject must be scheduled for robotic-assisted radical prostatectomy at the clinical site.

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frameDescription
Positive MarginImmediately postoperatively, expected same day as surgeryDetection of positive margin

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026